Clinical Trial Update: Evaluate the Efficacy and Safety of Adebrelimab Combined With Chemotherapy With or Without Radiotherapy as Neoadjuvant Treatment for HER2-Negative Locally Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial evaluating Adebrelimab with chemotherapy with or without radiotherapy for HER2-negative locally advanced breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: HER2-Negative Locally Advanced Breast Cancer | Phase 2 | Status: NOT_YET_RECRUITING